In Reply to 'Hemodialysis Catheters: Which Design Is More Cost-effective?' and 'Use of an Uncensored Primary Outcome in a Catheter Design Trial?'

被引:0
|
作者
De Vriese, An [1 ]
Van Der Meersch, Hans [1 ]
De Bacquer, Dirk [2 ]
机构
[1] AZ Sint Jan Brugge, Brugge, Belgium
[2] Univ Ghent, B-9000 Ghent, Belgium
关键词
D O I
10.1053/j.ajkd.2015.04.008
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:171 / 171
页数:1
相关论文
共 43 条
  • [1] Hemodialysis Catheters: Which Design Is More Cost-effective?
    AlBugami, Meteb M.
    Tennankore, Karthik K.
    Soroka, Steven D.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (01) : 170 - 170
  • [2] Use of an Uncensored Primary Outcome in a Catheter Design Trial?
    Ashby, Damien R.
    Corbett, Richard W.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (01) : 170 - 170
  • [3] Zanamivir vs Oseltamivir: Which drug is more cost-effective? Authors' reply
    Armstrong, EP
    Khan, ZM
    Perry, AS
    Perri, LR
    FORMULARY, 2001, 36 (05) : 384 - +
  • [4] In Reply to 'Training Can Be Cost-Effective in Reducing Morbidity Associated With Temporary Hemodialysis Catheter Insertion'
    Clark, Edward
    Edwards, Cedric
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (02) : 346 - 347
  • [5] THE USE OF A DOUBLE-LUMEN PERIPHERAL INTRAVENOUS CATHETER IS MORE COST-EFFECTIVE THAN 2 SINGLE-LUMEN INTRAVENOUS CATHETERS
    MALLORY, DL
    OBRIEN, JA
    EVANS, RG
    PIONTEK, D
    BACON, RS
    STICKLEY, LP
    VEREMAKIS, C
    CLINICAL RESEARCH, 1989, 37 (02): : A345 - A345
  • [6] INTRODUCING A COST-EFFECTIVE RADIOPAQUE SCALE DESIGN FOR INTRAOPERATIVE USE
    Dey, Roopam
    Beukes, Giancarlo
    Nair, Gokul
    Sivarasu, Sudesh
    PROCEEDINGS OF THE 2020 DESIGN OF MEDICAL DEVICES CONFERENCE (DMD2020), 2020,
  • [7] Design and implementation of a cost-effective microscopy setup for use at the undergraduate level
    Trout, Gregory M.
    Basu, Swarna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [8] Conjunctive use of models to design cost-effective ozone control strategies
    Fu, Joshua S.
    Brill, E. Downey, III
    Ranjithan, S. Ranji
    JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION, 2006, 56 (06) : 800 - 809
  • [9] Is it more cost-effective to use bevacizumab in the primary treatment setting or at recurrence? An economic analysis
    Fuh, K.
    Chan, J.
    Monk, B.
    Urban, R.
    Hu, L.
    Kapp, D.
    Caughey, A.
    Yu, X.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S98 - S98
  • [10] Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial
    Forster, Martin
    Brealey, Stephen
    Chick, Stephen
    Keding, Ada
    Corbacho, Belen
    Alban, Andres
    Pertile, Paolo
    Rangan, Amar
    CLINICAL TRIALS, 2021, 18 (06) : 647 - 656